Animal models for autism in 2017 and the consequential implications to drug discovery

References

• Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Pub Incorporated;Arlington, VA, American Psychiatric Association. 2013.
   Google Scholar
• Kazdoba TM, Leach PT, Yang M, et al. Translational mouse models of autism: advancing toward pharmacological therapeutics. Curr Top Behav Neurosci. 2016;28:1–52.
   PubMedGoogle Scholar
• Chadman KK, Yang M, Crawley JN. Criteria for validating mouse models of psychiatric diseases. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet. 2009;150B:1–11.
   PubMed Web of Science ®Google Scholar
• Moy SS, Nadler JJ, Young NB, et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res. 2007;176:4–20.
   PubMed Web of Science ®Google Scholar
• Moy SS, Nadler JJ, Perez A, et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004;3:287–302.
   PubMed Web of Science ®Google Scholar
• Meyza KZ, Blanchard DC. The BTBR mouse model of idiopathic autism – current view on mechanisms. Neurosci Biobehav Rev [Internet]. 2017;76. Available from: http://www.sciencedirect.com/science/article/pii/S0149763416305383
   Web of Science ®Google Scholar
• Guariglia SR, Chadman KK The BTBR T+tf/J (BTBR) Mouse Model of Autism. Autism-Open Access [Internet]. 2013. Available from: http://www.omicsgroup.org/journals/2165-7890/2165-7890-S1-009.php&&aid=9850
   Google Scholar
• McFarlane HG, Kusek GK, Yang M, et al. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav. 2008;7:152–163.
   PubMed Web of Science ®Google Scholar
• Yang M, Abrams DN, Zhang JY, et al. Low sociability in BTBR T + tf/J mice is independent of partner strain. Physiol Behav [Internet]. 2012. Available from: http://www.sciencedirect.com/science/article/pii/S0031938411005804
   Web of Science ®Google Scholar
• Yang M, Zhodzishsky V, Crawley JN. Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. Int J Dev Neurosci Off J Int Soc Dev Neurosci. 2007;25:515–521.
   PubMed Web of Science ®Google Scholar
• Pobbe RLH, Pearson BL, Defensor EB, et al. Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behav Brain Res. 2010;214:443–449.
   PubMed Web of Science ®Google Scholar
• Karvat G, Kimchi T. Systematic autistic-like behavioral phenotyping of 4 mouse strains using a novel wheel-running assay. Behav Brain Res. 2012;233:405–414.
   PubMed Web of Science ®Google Scholar
• Meyza KZ, Defensor EB, Jensen AL, et al. The BTBR T+tf/J mouse model for autism spectrum disorders–in search of biomarkers. Behav Brain Res. 2013;251:25–34.
   PubMed Web of Science ®Google Scholar
• Yang M, Loureiro D, Kalikhman D, et al. Male mice emit distinct ultrasonic vocalizations when the female leaves the social interaction arena. Front Behav Neurosci. 2013;7:159.
   PubMed Web of Science ®Google Scholar
• Karvat G, Kimchi T. Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of Autism. Neuropsychopharmacology. 2014;39:831–840.
   PubMed Web of Science ®Google Scholar
• Yang M, Zhodzishsky V, Crawley JN. Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. Int J Dev Neurosci. 2007;25:515–521.
   PubMed Web of Science ®Google Scholar
• Silverman JL, Tolu SS, Barkan CL, et al. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology. 2010;35:976–989.
   PubMed Web of Science ®Google Scholar
• Pearson BL, Pobbe RLH, Defensor EB, et al. Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism. Genes Brain Behav. 2011;10:228–235.
   PubMed Web of Science ®Google Scholar
• Gould GG, Hensler JG, Burke TF, et al. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. J Neurochem. 2011;116:291–303.
   PubMed Web of Science ®Google Scholar
• Amodeo DA, Jones JH, Sweeney JA, et al. Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Behav Brain Res. 2012;227:64–72.
   PubMed Web of Science ®Google Scholar
• Kazdoba TM, Hagerman RJ, Zolkowska D, et al. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacol (Berl). 2016;233:309–323.
   PubMed Web of Science ®Google Scholar
• Defensor EB, Pearson BL, Pobbe RLH, et al. A novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+ tf/J mice. Behav Brain Res. 2011;217:302–308.
   PubMed Web of Science ®Google Scholar
• Pobbe RLH, Defensor EB, Pearson BL, et al. General and social anxiety in the BTBR T+ tf/J mouse strain. Behav Brain Res. 2011;216:446–451.
   PubMed Web of Science ®Google Scholar
• Cai Y, Wang L, Xiao R, et al. Autism-like behavior in the BTBR mouse model of autism is improved by propofol. Neuropharmacology. 2017;118:175–187.
   PubMed Web of Science ®Google Scholar
• Silverman JL, Pride MC, Hayes JE, et al. GABAB receptor agonist Rbaclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism. Neuropsychopharmacology. 2015;40:2228–2239.
   PubMed Web of Science ®Google Scholar
• Brondino N, Fusar-Poli L, Panisi C, et al. Pharmacological modulation of GABA function in autism spectrum disorders: a systematic review of human studies. J Autism Dev Disord. 2016;46:825–839.
   PubMed Web of Science ®Google Scholar
• Silverman JL, Smith DG, Rizzo SJS, et al. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med. 2012;4:131ra51.
   PubMed Web of Science ®Google Scholar
• Yang H, Huh SO, Hong JS. Enhancement of short-term memory by methyl-6-(phenylethynyl)- mouse model of autism spectrum disorder. Endocrinol Metab Seoul Korea. 2015;30:98–104.
   PubMedGoogle Scholar
• Burket JA, Benson AD, Tang AH, et al. d-Cycloserine improves sociability in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling. Brain Res Bull. 2013;96:62–70.
   PubMed Web of Science ®Google Scholar
• Silverman JL, Oliver CF, Karras MN, et al. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology. 2013;64:268–282.
   PubMed Web of Science ®Google Scholar
• Fung LK, Hardan AY. Developing medications targeting glutamatergic dysfunction in autism: pProgress to date. CNS Drugs. 2015;29:453–463.
   PubMed Web of Science ®Google Scholar
• Amodeo DA, Yi J, Sweeney JA, et al. Oxotremorine treatment reduces repetitive behaviors in BTBR T+ tf/J mice. Front Synaptic Neurosci. 2014;6:17.
   PubMedGoogle Scholar
• Wang L, Almeida LEF, Spornick NA, et al. Modulation of social deficits and repetitive behaviors in a mouse model of autism: the role of the nicotinic cholinergic system. Psychopharmacol (Berl). 2015;232:4303–4316.
   PubMed Web of Science ®Google Scholar
• McTighe SM, Neal SJ, Lin Q, et al. The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex. PLoS One. 2013;8:e62189.
   PubMed Web of Science ®Google Scholar
• Bales KL, Solomon M, Jacob S, et al. Long-term exposure to intranasal oxytocin in a mouse autism model. Transl Psychiatry. 2014;4:e480.
   PubMed Web of Science ®Google Scholar
• Chadman KK. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav. 2011;97:586–594.
   PubMed Web of Science ®Google Scholar
• Kratsman N, Getselter D, Elliott E. Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model. Neuropharmacology. 2016;102:136–145.
   PubMed Web of Science ®Google Scholar
• D’Agostino G, Cristiano C, Lyons DJ, et al. Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice. Mol Metab. 2015;4:528–536.
   PubMed Web of Science ®Google Scholar
• Wang Y, Billon C, Walker JK, et al. Therapeutic effect of a synthetic RORα/γ agonist in an animal model of autism. ACS Chem Neurosci. 2016;7:143–148.
   PubMed Web of Science ®Google Scholar
• Burket JA, Benson AD, Tang AH, et al. Rapamycin improves sociability in the BTBR T+Itpr3tf/J mouse model of autism spectrum disorders. Brain Res Bull. 2014;100:70–75.
   PubMed Web of Science ®Google Scholar
• Xuan ICY, Hampson DR. Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PloS One. 2014;9:e104433.
   PubMed Web of Science ®Google Scholar
• Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun. 2010;24:881–897.
   PubMed Web of Science ®Google Scholar
• Brown AS, Sourander A, Hinkka-Yli-Salomäki S, et al. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry. 2014;19:259–264.
   PubMed Web of Science ®Google Scholar
• Wong H, Hoeffer C. Maternal IL-17A in autism. Exp Neurol 2017. Epub ahead of print [PMID: 28455196].
   Google Scholar
• Kim S, Kim H, Yim YS, et al. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature. 2017. Epub ahead of print [PMID: 28902840].
   Web of Science ®Google Scholar
• Shi L, Fatemi SH, Sidwell RW, et al. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci. 2003;23:297–302.
   PubMed Web of Science ®Google Scholar
• Naviaux JC, Schuchbauer MA, Li K, et al. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Transl Psychiatry. 2014;4:e400.
   PubMed Web of Science ®Google Scholar
• Naviaux RK, Zolkipli Z, Wang L, et al. Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model. PloS One. 2013;8:e57380.
   PubMed Web of Science ®Google Scholar
• Coiro P, Padmashri R, Suresh A, et al. Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders. Brain Behav Immun. 2015;50:249–258.
   PubMed Web of Science ®Google Scholar
• Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. Jama. 2013;309:1696–1703.
   PubMed Web of Science ®Google Scholar
• Bromley RL, Mawer GE, Briggs M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637–643.
   PubMed Web of Science ®Google Scholar
• Gandal MJ, Edgar JC, Ehrlichman RS, et al. Validating γ oscillations and delayed auditory responses as translational biomarkers of autism. Biol Psychiatry. 2010;68:1100–1106.
   PubMed Web of Science ®Google Scholar
• Mehta MV, Gandal MJ, Siegel SJ. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PloS One. 2011;6:e26077.
   PubMed Web of Science ®Google Scholar
• Kataoka S, Takuma K, Hara Y, et al. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharmacol. 2011;16:1–13.
   Web of Science ®Google Scholar
• Kim J-W, Seung H, Kwon KJ, et al. Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism. PloS One. 2014;9:e104927.
   PubMed Web of Science ®Google Scholar
• Kang J, Kim E. Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors. Front Mol Neurosci. 2015;8:17.
   PubMed Web of Science ®Google Scholar
• Baronio D, Castro K, Gonchoroski T, et al. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid. PLoS One. 2015;10:e0116363.
   PubMed Web of Science ®Google Scholar
• Ellenbroek B, Youn J. Rodent models in neuroscience research: is it a rat race?. Dis Model Mech. 2016;9:1079–1087.
   PubMed Web of Science ®Google Scholar
• Kummer KK, Hofhansel L, Barwitz CM, et al. Differences in social interaction- vs. cocaine reward in mouse vs. rat. Front Behav Neurosci. 2014;8:363.
   PubMed Web of Science ®Google Scholar
• Roullet FI, Lai JKY, Foster JA. In utero exposure to valproic acid and autism–a current review of clinical and animal studies. Neurotoxicol Teratol. 2013;36:47–56.
   PubMed Web of Science ®Google Scholar
• Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol 2017. Epub ahead of print [PMID: 28472621].
   PubMedGoogle Scholar
• Rodier PM, Ingram JL, Tisdale B, et al. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol. 1996;370:247–261.
   PubMed Web of Science ®Google Scholar
• Schneider T, Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2005;30:80–89.
   PubMed Web of Science ®Google Scholar
• Stanton ME, Peloso E, Brown KL, et al. Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism. Behav Brain Res. 2007;176:133–140.
   PubMed Web of Science ®Google Scholar
• Kumar H, Sharma B. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats. Brain Res Bull. 2016;124:27–39.
   PubMed Web of Science ®Google Scholar
• Wellmann KA, Varlinskaya EI, Mooney SM. D-Cycloserine ameliorates social alterations that result from prenatal exposure to valproic acid. Brain Res Bull. 2014;108:1–9.
   PubMed Web of Science ®Google Scholar
• Wu H-F, Chen PS, Hsu Y-T, et al. D-cycloserine ameliorates autism-like deficits by removing GluA2-containing AMPA receptors in a valproic acid-induced rat model. Mol Neurobiol. 2017. Epub ahead of print [PMID: 28733898].
   Google Scholar
• Kumar H, Sharma B. Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats. Brain Res. 2016;1630:83–97.
   PubMed Web of Science ®Google Scholar
• Kumar H, Sharma BM, Sharma B. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder. Neurochem Int. 2015;91:34–45.
   PubMed Web of Science ®Google Scholar
• Cuevas-Olguin R, Roychowdhury S, Banerjee A, et al. Cerebrolysin prevents deficits in social behavior, repetitive conduct, and synaptic inhibition in a rat model of autism. J Neurosci Res. 2017. Epub ahead of print [PMID: 28609577].
   PubMedGoogle Scholar
• Young KA, Gobrogge KL, Liu Y, et al. The neurobiology of pair bonding: insights from a socially monogamous rodent. Front Neuroendocrinol. 2011;32:53–69.
   PubMed Web of Science ®Google Scholar
• Insel TR, Shapiro LE. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc Natl Acad Sci U S A. 1992;89:5981–5985.
   PubMed Web of Science ®Google Scholar
• Modi ME, Young LJ. D-cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disorders. Biol Psychiatry. 2011;70:298–304.
   PubMed Web of Science ®Google Scholar
• Bauman MD, Iosif A-M, Smith SEP, et al. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol Psychiatry. 2014;75:332–341.
   PubMed Web of Science ®Google Scholar
• Yasue M, Nakagami A, Banno T, et al. Indifference of marmosets with prenatal valproate exposure to third-party non-reciprocal interactions with otherwise avoided non-reciprocal individuals. Behav Brain Res. 2015;292:323–326.
   PubMed Web of Science ®Google Scholar
• Meshalkina DA, Kizlyk MN, Kysil VE, et al. Zebrafish models of autism spectrum disorder. Exp Neurol. 2017. Epub ahead of print [PMID: 28163161].
   PubMedGoogle Scholar
• Stewart AM, Nguyen M, Wong K, et al. Developing zebrafish models of autism spectrum disorder (ASD). Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:27–36.
   PubMed Web of Science ®Google Scholar
• Bell AJ, McBride SMJ, Dockendorff TC. Flies as the ointment: drosophila modeling to enhance drug discovery. Fly (Austin). 2009;3:39–49.
   PubMed Web of Science ®Google Scholar
• Accordino RE, Kidd C, Politte LC, et al. Psychopharmacological interventions in autism spectrum disorder. Expert Opin Pharmacother. 2016;17:937–952.
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Frye RE. The use of medications approved for Alzheimer’s disease in autism spectrum disorder: a systematic review. Front Pediatr. 2014;2:87.
   PubMed Web of Science ®Google Scholar
• Erickson CA, Chambers JE. Memantine for disruptive behavior in autistic disorder. J Clin Psychiatry. 2006;67:1000.
   PubMed Web of Science ®Google Scholar
• Chez MG, Burton Q, Dowling T, et al. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol. 2007;22:574–579.
   PubMed Web of Science ®Google Scholar
• Aman MG, Findling RL, Hardan AY, et al. Safety and efficacy of memantine in children with autism: randomized, placebo-controlled study and open-label extension. J Child Adolesc Psychopharmacol. 2017;27:403–412.
   PubMed Web of Science ®Google Scholar
• Urbano M, Okwara L, Manser P, et al. A trial of d-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder. Clin Neuropharmacol. 2014;37:69–72.
   PubMed Web of Science ®Google Scholar
• Wink LK, Minshawi NF, Shaffer RC, et al. d-Cycloserine enhances durability of social skills training in autism spectrum disorder. Mol Autism. 2017;8:2.
   PubMed Web of Science ®Google Scholar
• Minshawi NF, Wink LK, Shaffer R, et al. A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders. Mol Autism. 2016;7:2.
   PubMed Web of Science ®Google Scholar
• Lord C, Risi S, DiLavore PS, et al. Autism from 2 to 9 years of age. Arch Gen Psychiatry. 2006;63:694–701.
   PubMed Web of Science ®Google Scholar